Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07535177

Gas6 and Soluble MerTK in Periodontal Diseases

Evaluation of Gas6 and Soluble MerTK Levels in Gingival Crevice Fluid in Individuals With Periodontal Health, Gingivitis, and Periodontitis

Status
Recruiting
Phase
Study type
Observational
Enrollment
90 (estimated)
Sponsor
Abant Izzet Baysal University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study aimed to investigate gingival crevicular fluid (GCF) and serum soluble MerTK (sMerTK) and Gas6 levels in periodontal health and disease. A total of 90 individuals, 30 patients with stage III grade B periodontitis, 30 with gingivitis and 30 periodontally healthy individuals were included. Whole-mouth and site-specific clinical periodontal parameters including probing depth, clinical attachment level, bleeding on probing, gingival index, plaque index were recorded. GCF and serum sMerTK and Gas6 levels were measured by enzyme-linked immunosorbent assay. Statistical analysis was performed by using non-parametric tests.

Conditions

Interventions

TypeNameDescription
OTHERgingival crevicular fluid collectionGingival crevicular fluid collection using sterile paper strips inserted into the gingival sulcus for 30 seconds from selected periodontal sites (healthy, gingivitis, and periodontitis) for biomarker analysis (Gas6 and sMerTK).

Timeline

Start date
2026-03-25
Primary completion
2026-05-10
Completion
2026-05-20
First posted
2026-04-16
Last updated
2026-04-16

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07535177. Inclusion in this directory is not an endorsement.